Sequential administration of XPO1 and ATR inhibitors enhances therapeutic response in TP53-mutated colorectal cancer.

Please login or register to bookmark this article
Bookmark this %label%

Understanding the mechanisms by which tumors adapt to therapy is critical for developing effective combination therapeutic approaches to improve clinical outcomes for patients with cancer.To identify promising and clinically actionable targets for managing colorectal cancer (CRC), we conducted a patient-centered functional genomics platform that includes approximately 200 genes and paired this with a high-throughput drug screen that includes 262 compounds in four patient-derived xenografts (PDXs) from patients with CRC.Both screening methods identified exportin 1 (XPO1) inhibitors as drivers of DNA damage-induced lethality in CRC. Molecular characterization of the cellular response to XPO1 inhibition uncovered an adaptive mechanism that limited the duration of response in TP53-mutated, but not in TP53-wild type CRC models. Comprehensive proteomic and transcriptomic characterization revealed that the ATM/ATR-CHK1/2 axes were selectively engaged in TP53-mutant CRC cells upon XPO1 inhibitor treatment, and that this response was required for adapting to therapy and escaping cell death. Administration of KPT-8602, an XPO1 inhibitor, followed by AZD-6738, an ATR inhibitor, resulted in dramatic antitumor effects and prolonged survival in TP53-mutant models of CRC.Our findings anticipate tremendous therapeutic benefit and support the further evaluation of XPO1 inhibitors, especially in combination with DNA damage checkpoint inhibitors, to elicit an enduring clinical response in patients with CRC harboring TP53 mutations.

View the full article @ Gastroenterology
Get PDF with LibKey

Authors: Akira Inoue, Frederick S Robinson, Rosalba Minelli, Hideo Tomihara, Bahar Salimian Rizi, Johnathon L Rose, Takahiro Kodama, Sanjana Srinivasan, Angela L Harris, Andy M Zuniga, Robert A Mullinax, Xiaoyan Ma, Sahil Seth, Joseph R Daniele, Michael D Peoples, Sara Loponte, Kadir C Akdemir, Tin Oo Khor, Ningping Feng, Jason Roszik, Mary M Sobieski, David Brunell, Clifford Stephan, Virginia Giuliani, Angela K Deem, Takashi Shingu, Yonathan Lissanu Deribe, David G Menter, Timothy P Heffernan, Andrea Viale, Christopher A Bristow, Scott Kopetz, Giulio F Draetta, Giannicola Genovese, Alessandro Carugo